Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Postoperative | 8 | 2019 | 1638 | 2.270 |
Why?
|
| Cesarean Section | 7 | 2021 | 1363 | 2.120 |
Why?
|
| Pregnancy Complications, Infectious | 9 | 2023 | 2026 | 2.120 |
Why?
|
| Labor, Obstetric | 2 | 2023 | 333 | 1.310 |
Why?
|
| Hepatitis B | 2 | 2022 | 695 | 1.050 |
Why?
|
| Pregnancy | 35 | 2023 | 29087 | 1.020 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2022 | 485 | 0.950 |
Why?
|
| Hepatitis B Vaccines | 2 | 2022 | 194 | 0.920 |
Why?
|
| Analgesics, Opioid | 5 | 2019 | 3667 | 0.880 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2023 | 140 | 0.830 |
Why?
|
| Chorioamnionitis | 1 | 2023 | 155 | 0.820 |
Why?
|
| Antibody Formation | 2 | 2022 | 1402 | 0.760 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 236 | 0.740 |
Why?
|
| Vaccination | 8 | 2023 | 3256 | 0.740 |
Why?
|
| Puerperal Disorders | 2 | 2019 | 275 | 0.670 |
Why?
|
| Fetal Blood | 2 | 2022 | 1317 | 0.650 |
Why?
|
| Bupivacaine | 2 | 2018 | 408 | 0.630 |
Why?
|
| Mass Screening | 4 | 2022 | 5238 | 0.620 |
Why?
|
| Delivery, Obstetric | 3 | 2021 | 904 | 0.620 |
Why?
|
| Prenatal Care | 2 | 2022 | 1088 | 0.590 |
Why?
|
| Immunoglobulin G | 4 | 2022 | 4554 | 0.560 |
Why?
|
| Gynecology | 1 | 2022 | 509 | 0.550 |
Why?
|
| Inappropriate Prescribing | 1 | 2018 | 202 | 0.540 |
Why?
|
| Cannabis | 1 | 2022 | 432 | 0.520 |
Why?
|
| Infertility | 1 | 2022 | 655 | 0.500 |
Why?
|
| Emergency Treatment | 1 | 2019 | 517 | 0.500 |
Why?
|
| Liposomes | 1 | 2018 | 758 | 0.500 |
Why?
|
| Maternal Health Services | 1 | 2020 | 452 | 0.490 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 469 | 0.480 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 365 | 0.470 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2017 | 336 | 0.460 |
Why?
|
| Placenta | 2 | 2022 | 1694 | 0.460 |
Why?
|
| Acetaminophen | 1 | 2017 | 544 | 0.450 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 1232 | 0.440 |
Why?
|
| Narcotic Antagonists | 1 | 2017 | 562 | 0.430 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 1364 | 0.430 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 3164 | 0.430 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 5385 | 0.420 |
Why?
|
| Fetal Diseases | 1 | 2017 | 903 | 0.420 |
Why?
|
| Rickettsia Infections | 1 | 2011 | 9 | 0.410 |
Why?
|
| Postpartum Period | 2 | 2023 | 1078 | 0.400 |
Why?
|
| Decision Support Techniques | 2 | 2022 | 1952 | 0.390 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 984 | 0.390 |
Why?
|
| Q Fever | 1 | 2011 | 37 | 0.390 |
Why?
|
| Papillomavirus Vaccines | 1 | 2016 | 489 | 0.370 |
Why?
|
| Female | 42 | 2023 | 379592 | 0.360 |
Why?
|
| Spouse Abuse | 1 | 2011 | 178 | 0.340 |
Why?
|
| Fever | 2 | 2019 | 1612 | 0.330 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 253 | 0.330 |
Why?
|
| Immunoglobulin M | 3 | 2022 | 1538 | 0.320 |
Why?
|
| Data Collection | 1 | 2017 | 3339 | 0.320 |
Why?
|
| Anemia | 1 | 2017 | 1499 | 0.300 |
Why?
|
| Research Design | 1 | 2022 | 5979 | 0.270 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 2062 | 0.270 |
Why?
|
| Hemorrhage | 1 | 2017 | 3461 | 0.270 |
Why?
|
| Hypertension | 2 | 2023 | 8455 | 0.260 |
Why?
|
| Humans | 44 | 2023 | 742088 | 0.260 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 970 | 0.250 |
Why?
|
| Infant, Newborn | 8 | 2023 | 25575 | 0.250 |
Why?
|
| Opiate Substitution Treatment | 2 | 2019 | 404 | 0.240 |
Why?
|
| Embryo Transfer | 3 | 2022 | 511 | 0.230 |
Why?
|
| Adult | 19 | 2023 | 213712 | 0.230 |
Why?
|
| Tetanus | 1 | 2023 | 53 | 0.220 |
Why?
|
| Diphtheria | 1 | 2023 | 35 | 0.220 |
Why?
|
| Eclampsia | 1 | 2023 | 58 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7153 | 0.220 |
Why?
|
| Pregnant Women | 3 | 2022 | 566 | 0.210 |
Why?
|
| Decision Making | 2 | 2018 | 3869 | 0.200 |
Why?
|
| Hepatitis B Antibodies | 1 | 2022 | 159 | 0.200 |
Why?
|
| Women's Health | 1 | 2011 | 2034 | 0.190 |
Why?
|
| Analgesia, Obstetrical | 2 | 2021 | 177 | 0.190 |
Why?
|
| Vital Signs | 1 | 2022 | 141 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7901 | 0.190 |
Why?
|
| Pregnancy, Multiple | 1 | 2021 | 217 | 0.190 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2020 | 45 | 0.180 |
Why?
|
| Vertebral Artery Dissection | 1 | 2020 | 48 | 0.180 |
Why?
|
| Immunization, Secondary | 1 | 2022 | 340 | 0.180 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 30 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 992 | 0.170 |
Why?
|
| Transportation | 1 | 2020 | 211 | 0.170 |
Why?
|
| Markov Chains | 1 | 2022 | 969 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2022 | 77098 | 0.160 |
Why?
|
| Blood Pressure Determination | 1 | 2022 | 632 | 0.160 |
Why?
|
| Progesterone | 1 | 2022 | 773 | 0.160 |
Why?
|
| Term Birth | 1 | 2018 | 135 | 0.160 |
Why?
|
| Models, Economic | 1 | 2022 | 713 | 0.150 |
Why?
|
| Uterine Diseases | 1 | 2019 | 135 | 0.150 |
Why?
|
| Oocyte Retrieval | 1 | 2018 | 161 | 0.150 |
Why?
|
| Logistic Models | 3 | 2018 | 13403 | 0.150 |
Why?
|
| Fertility | 1 | 2022 | 770 | 0.140 |
Why?
|
| Fertilization in Vitro | 2 | 2022 | 1284 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2022 | 1254 | 0.140 |
Why?
|
| Self Care | 1 | 2022 | 786 | 0.140 |
Why?
|
| Tanzania | 2 | 2011 | 1344 | 0.140 |
Why?
|
| Gestational Age | 2 | 2022 | 3490 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2018 | 9846 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 2861 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 1679 | 0.130 |
Why?
|
| Parity | 1 | 2018 | 929 | 0.130 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 2795 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1589 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1196 | 0.120 |
Why?
|
| United States | 6 | 2022 | 69693 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
| Infant | 3 | 2022 | 35070 | 0.110 |
Why?
|
| Young Adult | 9 | 2021 | 56350 | 0.110 |
Why?
|
| Ischemia | 1 | 2022 | 1911 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3130 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3236 | 0.100 |
Why?
|
| India | 1 | 2018 | 2187 | 0.100 |
Why?
|
| Rickettsia conorii | 1 | 2011 | 1 | 0.100 |
Why?
|
| Rickettsia typhi | 1 | 2011 | 5 | 0.100 |
Why?
|
| Bacteremia | 1 | 2019 | 962 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 1032 | 0.100 |
Why?
|
| Coxiella burnetii | 1 | 2011 | 37 | 0.100 |
Why?
|
| World Health Organization | 1 | 2016 | 1317 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2022 | 53187 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2020 | 2049 | 0.090 |
Why?
|
| Obstetrics | 1 | 2017 | 657 | 0.090 |
Why?
|
| Birth Weight | 1 | 2018 | 2068 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1402 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2022 | 21719 | 0.090 |
Why?
|
| Premature Birth | 1 | 2021 | 1713 | 0.080 |
Why?
|
| Sepsis | 1 | 2023 | 2589 | 0.080 |
Why?
|
| Marital Status | 1 | 2011 | 437 | 0.080 |
Why?
|
| Unemployment | 1 | 2011 | 214 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1636 | 0.080 |
Why?
|
| Personal Autonomy | 1 | 2011 | 297 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2018 | 3418 | 0.080 |
Why?
|
| HIV Infections | 2 | 2011 | 16678 | 0.080 |
Why?
|
| Critical Care | 1 | 2020 | 2640 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2706 | 0.070 |
Why?
|
| Prevalence | 3 | 2020 | 15194 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2276 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2022 | 8541 | 0.070 |
Why?
|
| Adolescent | 6 | 2020 | 85649 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13029 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15056 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2018 | 3300 | 0.070 |
Why?
|
| Ethics, Medical | 1 | 2011 | 791 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3611 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3510 | 0.060 |
Why?
|
| Health Resources | 1 | 2011 | 911 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2022 | 40450 | 0.060 |
Why?
|
| Magnesium Sulfate | 1 | 2023 | 68 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2018 | 3738 | 0.060 |
Why?
|
| Educational Status | 1 | 2011 | 2533 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 62966 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 304 | 0.050 |
Why?
|
| Acute Disease | 1 | 2011 | 7141 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 72145 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2022 | 248 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 297 | 0.050 |
Why?
|
| Pregnancy, High-Risk | 1 | 2020 | 120 | 0.040 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 26 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2022 | 689 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 773 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10578 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 2022 | 643 | 0.040 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2021 | 235 | 0.040 |
Why?
|
| Uncertainty | 1 | 2023 | 725 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 706 | 0.040 |
Why?
|
| Peripartum Period | 1 | 2019 | 133 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2020 | 322 | 0.040 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2019 | 109 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2022 | 664 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 506 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39004 | 0.040 |
Why?
|
| Substance Abuse Detection | 1 | 2019 | 283 | 0.030 |
Why?
|
| Education | 1 | 2019 | 543 | 0.030 |
Why?
|
| Middle Aged | 4 | 2020 | 213127 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 2021 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2021 | 1164 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18355 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2020 | 983 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2043 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 1970 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2018 | 784 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2021 | 2041 | 0.030 |
Why?
|
| Hospitalization | 1 | 2011 | 10232 | 0.030 |
Why?
|
| Seizures | 1 | 2023 | 2851 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1339 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8328 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 24913 | 0.020 |
Why?
|
| Male | 2 | 2022 | 349538 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23320 | 0.020 |
Why?
|
| Child | 2 | 2020 | 77478 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1794 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 40955 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7317 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3740 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8077 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14720 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3306 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4250 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5304 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19862 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 20928 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 162944 | 0.010 |
Why?
|
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_